M&A

Biopharma Firm Finalizes Takeover of French Immuno-Oncology Specialist
3 days ago

Biopharma Firm Finalizes Takeover of French Immuno-Oncology Specialist

Pharmaceutical Manufacturer Gaelic Labs Acquires Athlone Laboratories
4 days ago

Pharmaceutical Manufacturer Gaelic Labs Acquires Athlone Laboratories

Major Biotech Deal: Sobi Acquires Arthrosi in Transaction Valued Up to $1.5 Billion
4 days ago

Major Biotech Deal: Sobi Acquires Arthrosi in Transaction Valued Up to $1.5 Billion

Mirum Pharmaceuticals Expands Portfolio With Bluejay Therapeutics Acquisition
2 weeks ago

Mirum Pharmaceuticals Expands Portfolio With Bluejay Therapeutics Acquisition

Viatris Exits Preferred Equity Stake in Biocon Biologics in Major Transaction
2 weeks ago

Viatris Exits Preferred Equity Stake in Biocon Biologics in Major Transaction

Sandoz Finalizes Acquisition of Just-Evotec Biologics EU SAS, Reinforcing Biosimilars Leadership
2 weeks ago

Sandoz Finalizes Acquisition of Just-Evotec Biologics EU SAS, Reinforcing Biosimilars Leadership

Pharma Megamerger: Major Drug Company Unifies $5.5 Billion Biologics Subsidiary
2 weeks ago

Pharma Megamerger: Major Drug Company Unifies $5.5 Billion Biologics Subsidiary

Minimum Acceptance Threshold Met in Exchange Proposal Between Two Biotech Firms
2 weeks ago

Minimum Acceptance Threshold Met in Exchange Proposal Between Two Biotech Firms

Eli Lilly Secures Experimental Cancer Therapy from Scorpion in Up-to-$2.5 Billion Deal
2 weeks ago

Eli Lilly Secures Experimental Cancer Therapy from Scorpion in Up-to-$2.5 Billion Deal

📰 Novartis Acquires Anthos Therapeutics for Up to $3.1 Billion to Boost Cardiovascular Pipeline
2 weeks ago

📰 Novartis Acquires Anthos Therapeutics for Up to $3.1 Billion to Boost Cardiovascular Pipeline

Merck Finalizes $3.4 Billion Acquisition, Enhancing Rare Tumor Portfolio
2 weeks ago

Merck Finalizes $3.4 Billion Acquisition, Enhancing Rare Tumor Portfolio

Roche Commits $3.5 Billion to Bolster MASH Portfolio via 89bio Acquisition
2 weeks ago

Roche Commits $3.5 Billion to Bolster MASH Portfolio via 89bio Acquisition

Novo Nordisk Secures Key MASH Therapy in $5.2 Billion Strategic Deal
2 weeks ago

Novo Nordisk Secures Key MASH Therapy in $5.2 Billion Strategic Deal

Merck Finalizes $10 Billion Acquisition of Verona Pharma with No Competing Bids
2 weeks ago

Merck Finalizes $10 Billion Acquisition of Verona Pharma with No Competing Bids

Johnson & Johnson Expands Neuroscience Portfolio with $14.6 Billion Acquisition
2 weeks ago

Johnson & Johnson Expands Neuroscience Portfolio with $14.6 Billion Acquisition

Pharmaceutical Giant Finalizes Acquisition of Obesity Drug Developer
2 weeks ago

Pharmaceutical Giant Finalizes Acquisition of Obesity Drug Developer

© Copyright 2025, All Rights Reserved  |  by TieLabs | Design by Trịnh Trúc
Back to top button